Strong order book, sequenced growth; margin boost from land sales, execution risk ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Management reiterated FY27-FY29 guidance without change; Q2 delivery aligns with opening remarks. Execution track record mixed: Amrapali phased completion progressing but delayed vs original timeline; award conversion still pending on key tenders.
Optimistic
next 1–2 quarters
Optimistic
multi-year
NBCC has delivered strong sequential growth (₹3,396 Cr, +50% QoQ) on a record ₹1,26,000 Cr order book and is reaffirming FY27 ₹16,000-17,000 Cr guidance with ₹1,100-1,200 Cr PAT target on track. Multi-year trajectory to ₹24,000-25,000 Cr (FY29) with concrete pipeline (₹15,000-16,000 Cr new awards expected) justifies bullish long-term stance. However, margin expansion is partly driven by non-recurring marketing fees (₹250 Cr estimated) from land monetization, and near-term execution risk on large government/redevelopment projects caps upside in the next 1-2 quarters.
₹3395.8 Cr
Revenue · +16.7% YoY₹209.8 Cr
Reported PAT · +33.9% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 consolidated revenue 3,396 Cr with 38% standalone growth
METConsolidated revenue ₹3,395.8 Cr confirmed; standalone 38% YoY growth supported by opening remarks (₹2,890 Cr standalone vs Q2 FY26 ~₹2,094 Cr)
EBITDA expanded 105-154% YoY; PAT grew 31-34% YoY
METDelivered PAT growth 33.9% YoY matches call claim of 31%; EBITDA expansion confirmed by margin trajectory (OPM 6.6%, higher than prior year implied)
Expected ₹15,000-16,000 Cr new orders this fiscal
METQ2 secured ₹3,600 Cr; pipeline includes Supertech ₹9,600 Cr, West Bengal ₹10,000 Cr, Bihar ₹2,000-3,000 Cr, J&K. Claim appears achievable but not yet materialized.
Marketing fees ₹100 Cr in H1, ₹250 Cr target for full year from land monetization
METLand parcel sales (Jaipur ₹433 Cr sale value, ₹200 Cr profit in Q2) and additional Q3 sales expected ~₹400 Cr. Trajectory credible but depends on real estate market and completion timing.
Order book ₹1,26,000 Cr consolidated, ₹50,000-60,000 Cr inflows target
METOrder book size stated in call; inflows on track with Q2 secured ₹3,600 Cr + large pending awards. Still contingent on tender closures.
Earnings quality
What changed since the last call
FY28 revenue guidance range widened
UpgradePrior call: ₹21,000 Cr. Current: ₹21,000-22,000 Cr (if ₹20,000 Cr awarded). Confidence in 25% growth maintained; upside case clearer.
Real estate monetization strategy clarified
NewManagement now openly targeting ₹1,600 Cr market value of land parcels for sale (~₹250 Cr marketing fees over 2-3 years). New revenue stream; profit realization in bulk will be ₹400 Cr+ (per closing remarks: ₹239 Cr aggregate profit from Jaipur + other parcels).
Order inflows cadence detail
UpgradeSpecificity on ₹15,000-16,000 Cr awards this fiscal now broken down: Supertech ₹9,600 Cr, West Bengal ₹10,000 Cr, Bihar ₹2,000-3,000 Cr, J&K, Rajasthan, other state work. Prior call was aggregate ₹50,000-60,000 Cr; now quarterly visibility emerging.
Amrapali technology upgrade
NeutralSwitched to Mivan shuttering and precast technology for faster execution (Phase-2). Phase-1 completed despite 1-2 year delay; now confident on 24-month Phase-2 delivery pace.
Dubai execution timeline
NeutralRERA registration pending Dec 2026. Groundbreaking end-Dec 2026/early-Jan 2027 confirmed by management. Initial sales phase expected end-Dec 2026 or Jan 2027 (post-possession recognition).
The Q&A
Analysts pressed hard on order book conversion timelines, execution bottlenecks (Amrapali delays, Supertech award pending, environmental restrictions in Delhi), and working capital intensity. Management held firm on guidance and provided detailed project/tender status, acknowledging delays as temporary (Amrapali now 24/22 Phase-1 complete, Supertech tender imminent). Q&A tone was professional; evasion on HUDCO funding for MAHAPREIT was brief but explained (funding on-going, not blocker). No major pushback conceded; management confident on execution.
FY27 Guidance and H2 execution — Pankaj Kumar, Kotak Neo
AnsweredFY27 standalone ₹13,000-14,000 Cr; consolidated ₹16,000-17,000 Cr will be achieved (reaffirmed). FY28 ₹21,000-22,000 Cr (25% growth), FY29 ₹24,000-25,000 Cr with ₹21,000 Cr committed already at consolidated level.
Order inflows pipeline — Pankaj Kumar, Kotak Neo
Answered₹50,000-60,000 Cr inflows on track. Supertech ₹9,600 Cr award imminent this quarter. GPRA/MAHAPREIT delays due to approvals/funding, but HUDCO funding ongoing. Rajasthan Mandapam order ₹8,000 Cr coming this quarter. Expected ₹30,000-35,000 Cr from 5 GPRA; West Bengal and Bihar orders also progressing.
EBITDA margin drivers and sustainability — Vasudev Ganatra, Nuvama
AnsweredEBITDA at 8% includes marketing fees on self-sustainable project sales (₹100 Cr H1, ₹250 Cr FY27 target). Revenue increase also helped. Cost structure is fixed, so higher revenue improves margins naturally. Marketing fee is perennial income but tied to sales volume.
Land parcel monetization value and timing — Vikas (analyst)
AnsweredQ2: Jaipur parcel ₹433 Cr sale value (₹195 Cr book value), ~₹200 Cr profit. Total land inventory ₹1,600 Cr market value, ~₹1,400 Cr in pipeline for auction (Meerut, Ghaziabad). Expect ₹250 Cr land sales Q3 realization; Q4 additional parcels.
West Bengal and state government order pipeline — Sumeet Rohra, Smartsun Capital
AnsweredNine MoUs signed with West Bengal departments (slum, municipal, urban dev., Kolkata projects). Pink Toilets, China Bazar, USP/redevelopment models. Q4 start for Pink Toilets. Other projects will come to kitty. Execution pace 18-24 months for awarded work; fresh projects 3-4 years for large redevelopment.
Amrapali execution progress and Phase-2 timeline — Sumeet Rohra, Smartsun Capital
AnsweredPhase-1: 24/22 projects complete on self-sustainable mode. Phase-2: ₹8,000 Cr workload, 26 floors in one package already reached. Using Mivan shuttering for faster execution. By end-FY27, ₹40,000 Cr running projects expected (₹32,000 Cr now + ₹10,000 Cr new execution + ₹15,000-16,000 Cr awards).
Order book bottleneck and award frequency — Komal Chaudhary, Ratnvali
AnsweredMAHAPREIT delayed by approvals. Jammu & Kashmir tendering in process (~₹2,000 Cr already awarded). Supertech award coming this/next month (~₹10,000 Cr total). West Bengal and Bihar adding ₹10,000-12,000 Cr. State governments now allowing PSUs to execute work (historic bar removed). Total ₹15,000-16,000 Cr this fiscal; minimum, says management.
FY28 revenue and PAT targets — Ravi Kumar Naredi, Naredi Investments
PartialFY28 revenue: ₹20,000-21,000 Cr (if ₹20,000 Cr awarded this year, plus running base growth). PAT: ₹1,500 Cr (implied from prior guidance trajectory). 25% growth assumption holds if execution pace maintained.
Dubai expansion and NBCC Australia sales — Vasudev Ganatra, Nuvama
AnsweredRERA registration and groundbreaking Dec 2026. Sales phase planned end-Dec 2026 or Jan 2027. Cash received post-possession, revenue recognized post-completion. Margins on real estate ~50% gross margin typically.
Timeline for order award conversions and tender delays — Komal Chaudhary, Ratnvali
AnsweredAQI stops only affect Delhi projects; other regions (Gurgaon, Noida) unaffected. All 5 GPRA projects awarded; Supertech already tendered (will award this month itself per recent update). 5 GPRA completion on track; state government work expanding to Goa, Karnataka, other states.
Ghitorni and Sector 37-D monetization timing — Vasudev Ganatra, Nuvama
AnsweredGhitorni: 4-4.5 lac sq. ft residential. Final MOU to be executed by quarter-end. Sales launch targeted Jan 2027 onwards. Cash received post-possession only; revenue post-completion. Sector 37-D: MoU execution in-process; tender already called. Award coming.
Guidance
FY27 consolidated ₹16,000-17,000 Cr
HighH1 ₹5,655 Cr; need ₹10,345-11,345 Cr H2. Expected ₹15,000-16,000 Cr awards this fiscal will materialize into FY28 revenue, but current award conversion and Q2 momentum (₹3,396 Cr) suggest H2 ramp-up achievable. Management committed; execution on track.
FY28 consolidated ₹21,000-22,000 Cr (implied 25% growth)
MediumAssumes ₹15,000-16,000 Cr awards convert to H2 FY27/FY28 revenue, ₹16,000+ Cr running base continues. Execution risk on new government tenders (West Bengal, Bihar, J&K) and project delivery pace. Doable but contingent on award closures and client payment cycles.
FY29 consolidated ₹24,000-25,000 Cr (continued growth)
MediumAssumes ₹50,000-60,000 Cr inflows this fiscal fully convert; new awards in FY28 added; running base ₹40,000 Cr executing. Long-term trajectory credible but subject to execution, government policy continuity, and working capital constraints.
EBITDA margin FY27 ~8% (with marketing fees), sustainable core ~6-6.5%
MediumQ2 8% EBITDA includes ₹100 Cr H1 marketing fees (~1.8% of H1 revenue). Core margin (ex-fees) ~6.2%, reflecting fixed cost absorption and volume growth. FY27 full-year expected ~7.5-8% if ₹250 Cr marketing fees materialize; FY28 normalization to 6.5-7% likely if land sales moderate.
PAT margin FY27 ~6.5-7% (with marketing fee benefit)
MediumQ2 NPM 6.1%; H1 implied ~6.2%. FY27 PAT target ₹1,100-1,200 Cr on ₹16,000-17,000 Cr revenue = 6.5-7.5% margin. Achievable with marketing fees and volume; dependent on tax rate and finance cost. FY28 PAT ₹1,500 Cr implied on ₹21,000-22,000 Cr = 6.8-7.1%, reflecting no margin expansion beyond FY27.
No explicit capex guidance; project-based execution model
LowNBCC is order-book driven (client funds projects). Own capex for equipment/Mivan shuttering technology mentioned (new Amrapali Phase-2 investment); no quantum disclosed. Working capital intensity high due to ₹1,26,000 Cr order book; debt/equity impact not discussed on call.
Risks the call surfaced
Execution/Project delivery
Medium₹1,26,000 Cr order book concentrated in complex redevelopment (Amrapali, 7 GPRA, government work). Amrapali Phase-1 faced ~2-year Supreme Court delays; Phase-2 pace unproven. Failed execution would cascade to FY27-FY28 revenue and PAT targets.
Order conversion pipeline
Medium₹15,000-16,000 Cr FY27 new awards target largely not yet materialized (Q2 only ₹3,600 Cr secured YTD). Supertech ₹9,600 Cr, West Bengal ₹10,000 Cr, Bihar ₹2,000-3,000 Cr, etc. all still in tender/MOU phase. Delays would push awards to Q4 FY27 or later, impacting FY28 revenue materialization.
Margin sustainability
MediumQ2-H1 EBITDA margin 8% partly inflated by ₹100 Cr H1 marketing fees (non-recurring land monetization income). Core margin ~6-6.5% is modest for a ₹1.26L Cr order book company. If land sales moderate post-FY27, EBITDA margin normalizes to 6.5-7%, limiting PAT growth to volume expansion only.
Government policy/regulation
MediumDelhi construction stops due to AQI spikes; West Bengal/Bihar/J&K tenders subject to government election cycles and policy changes (e.g., ban on PSU work historically; now being lifted). Rajasthan Mandapam order delayed by election Code of Conduct. Dependency on government budget cycles and tender processes introduces unpredictability.
Working capital/Debt intensity
Low₹1,26,000 Cr order book with 6+ years execution horizon implies significant working capital tied up and potential debt financing needs. No balance sheet/debt/liquidity metrics disclosed on call; cash flow profile not discussed. Stress could arise if client payment cycles extend or project cost overruns occur.
Management
Score 8/10. Chairman K.P. Mahadevswamy provided detailed answers with project specifics, order sizes, timelines, and execution metrics. Directors (Finance, Commercial, Projects) supported with breakdowns on margins, marketing fees, phased execution. Transparency on delays (Amrapali, Rajasthan tender), environmental restrictions, and challenges evident. No evasion except brief HUDCO funding clarification (deferred to 'ongoing'). Track record mixed: Amrapali Phase-1 completed after ~2-year Supreme Court delays, now in Phase-2 with new technology. 7 GPRA and other PMC projects in progress; no major cost/timeline overruns cited. Recent West Bengal MoU execution (9 in one day) and Jaipur land parcel monetization (successful auction) show capability.
1 · Q3 FY27 (Dec 2026)
Jaipur land parcel monetization (~₹400 Cr revenue, ₹200+ Cr profit expected)
2 · Dec 2026
Dubai NBCC Australia office groundbreaking ceremony (RERA registration pending)
3 · Q4 FY27 (Mar 2027)
Ghitorni project sales launch (4-4.5 lac sq. ft residential, MOU execution pending); Sector 37-D launch
However, margin expansion is partly driven by non-recurring marketing fees (₹250 Cr estimated) from land monetization, and near-term execution risk on large government/redevelopment projects caps upside in the next 1-2 quarters.
Informational and educational content only. Not investment advice.